4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Wave Life Sciences Ltd. (WVE) operates in the Biotechnology industry and is headquartered in Singapore, Singapore with about 317 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, WVE reported $43M in revenue and ($204M) in net income.
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.
Interactive charts & full statements → Open the WVE valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $43M | $108M | $113M | $4M |
| Operating Income (EBIT) | ($215M) | ($110M) | ($68M) | ($163M) |
| Net Income | ($204M) | ($97M) | ($58M) | ($162M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $38M | $17M | $8M | $9M | $9M | — |
| Operating Income (EBIT) | ($31M) | ($56M) | ($56M) | ($53M) | ($50M) | — |
| Net Income | ($26M) | ($53M) | ($54M) | ($50M) | ($47M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $638M | $352M | $275M | $146M |
| Total Liabilities | $120M | $143M | $235M | $192M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WVE viewer.
About TickerBase · Data methodology & sources